Literature DB >> 12022926

Ultrasonic tissue characterization and Doppler tissue imaging in the analysis of left ventricular function in essential arterial hypertension: a preliminary study.

Davide Giorgi1, Vitantonio Di Bello, Roberto Pedrinelli, Alessio Bertini, Enrica Talini, Giulia Dell'Omo, Giovanna Mengozzi, Caterina Palagi, Rita Dell'Anna, Mario Mariani.   

Abstract

It is not known if diastolic abnormalities are independent of systolic dysfunction in arterial hypertension. We studied three groups of 10 male subjects of comparable mean age (31.6 +/- 3.5 years), weight, and height: Athletes (A) (cyclists), essential hypertensive patients (H), and controls (C). Ultrasonic myocardial integrated backscatter signals (IBS) of the septum and the posterior wall were analyzed, while the systo-diastolic variation of the backscatter was considered as a cyclic variation index (CVI(ibs)). Myocardial velocities across the left ventricular major axis were sampled at septum and lateral wall levels by pulsed-wave Doppler tissue imaging (DTI). CVI(ibs) at the septum and the posterior wall were significantly lower in the hypertensive group in comparison with athletes and controls, who were comparable. Early diastolic myocardial velocity (E(m)) of the lateral wall and of the septum were significantly lower in hypertensives, while the late diastolic myocardial velocity (A(m)) was significantly higher in hypertensives in comparison with athletes. The E(m)/A(m) at the septum level was significantly lower in hypertensives in comparison with athletes and controls. Significant correlations were found between CVI and DTI parameters: CVI(ibs) and E(m)/A(m) septum (r = 0.50, P < 0.002). Furthermore, significant correlations were found between mean arterial pressure (MAP) and E(m)/A(m) septum (r = - 0.65, P < 0.001). Ultrasonic tissue characterization with the intrinsic contractility study and the evaluation of the regional diastolic function should, therefore, represent a new integrated diagnostic modality for the evaluation of left ventricular hypertrophied intramyocardial function. This study demonstrated that diastolic abnormalities of left ventricular function, in arterial hypertension, are related and progress with systolic intrinsic dysfunction.

Entities:  

Mesh:

Year:  2002        PMID: 12022926     DOI: 10.1046/j.1540-8175.2002.00187.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

1.  Impact of prehypertension on left ventricular structure, function and geometry.

Authors:  Jugal Kishore Bajpai; Sahay A P; Agarwal A K; De A K; Bindu Garg; Ashish Goel
Journal:  J Clin Diagn Res       Date:  2014-04-15

2.  Early and late improvement of global and regional left ventricular function after transcatheter aortic valve implantation in patients with severe aortic stenosis: an echocardiographic study.

Authors:  Cristina Giannini; Anna Sonia Petronio; Enrica Talini; Marco De Carlo; Fabio Guarracino; Maria Grazia; Delle Donne; Carmela Nardi; Lorenzo Conte; Valentina Barletta; Mario Marzilli; Vitantonio Di Bello
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

3.  Myocardial systolic strain abnormalities in patients with acromegaly: a prospective color Doppler imaging study.

Authors:  V Di Bello; F Bogazzi; A Di Cori; C Palagi; M G Delle Donne; S Gavioli; E Talini; C Cosci; C Sardella; G Tonti; E Martino; A Balbarini; M Mariani
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

4.  Pulsed tissue Doppler imaging of the left ventricular septal mitral annulus in healthy dogs.

Authors:  Jihye Choi; Hyunwook Kim; Junghee Yoon
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

5.  Early abnormalities of left ventricular myocardial characteristics associated with subclinical hyperthyroidism.

Authors:  V Di Bello; F Aghini-Lombardi; F Monzani; E Talini; L Antonangeli; C Palagi; A Di Cori; N Caraccio; M G Delle Donne; A Dardano; A Pinchera; M Mariani
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.